Sustained release formulation for oral administration of HMG-CoA reductase inhibitor and method for the preparation thereof
Number of patents in Portfolio can not be more than 2000
United States of America Patent
Stats
-
Jul 2, 2013
Grant Date -
Aug 23, 2007
app pub date -
Apr 8, 2005
filing date -
Apr 10, 2004
priority date (Note) -
In Force
status (Latency Note)
Importance
Abstract
The sustained release formulation for oral administration of an HMG-CoA reductase inhibitor of the present invention can be easily and economically prepared and is capable of maintaining a constant drug level in blood by slowly releasing the HMG-CoA reductase inhibitor at a uniform rate for 24 hrs. Accordingly, the sustained release formulation of the present invention can be effectively used for lowering blood cholesterol and triglyceride levels.
First Claim
Family
International Classification(s)
Cited Art Landscape
Patent Citation Ranking
Recipient Email Address
Recipient Email Address
Comment
Recipient Email Address
Add to Portfolio(s)
To add this patent to one, or more, of your portfolios, simply click the add button.
This Patent is in these Portfolios:
Add to additional portfolios:
Last Refreshed On:
Changes done successfully